| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.43 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |